Refractory Primary Duodenal Plasmacytoma Displaying t(11;14): A Report of a Rare Case

Extramedullary plasmacytoma (EMP) involving the digestive tract is a very rare entity that represents only a very small fraction of multiple myeloma (MM) cases. We describe an unusual case of a 71-year-old man with EMP involving the duodenum who initially presented to the emergency room with melena. The final diagnosis was duodenal plasmacytoma with t(11;14), and the diagnosis was reached by fibroscopy with biopsy and immunohistochemistry (IHC). The patient received local radiotherapy and showed failure three months after treatment. Then, he was administered daratumumab-based treatment associated with Revlimid and dexamethasone (DRD). To our knowledge, this is the first report showing duodenal involvement by EMP with t(11;14).

Authors

Institutions

Publication Details

Journal
Cureus
Published
2025-05-20
DOI
https://doi.org/10.7759/cureus.84443
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refractory Primary Duodenal Plasmacytoma Displaying t(11;14): A Report of a Rare Case

Marlène Ochmann, Nora El Maachi, Claire Belchet
Cureus
Multiple Myeloma Research and Treatments
article

Refractory Primary Duodenal Plasmacytoma Displaying t(11;14): A Report of a Rare Case

Marlène Ochmann, Nora El Maachi, Claire Belchet
article en

Abstract

Extramedullary plasmacytoma (EMP) involving the digestive tract is a very rare entity that represents only a very small fraction of multiple myeloma (MM) cases. We describe an unusual case of a 71-year-old man with EMP involving the duodenum who initially presented to the emergency room with melena. The final diagnosis was duodenal plasmacytoma with t(11;14), and the diagnosis was reached by fibroscopy with biopsy and immunohistochemistry (IHC). The patient received local radiotherapy and showed failure three months after treatment. Then, he was administered daratumumab-based treatment associated with Revlimid and dexamethasone (DRD). To our knowledge, this is the first report showing duodenal involvement by EMP with t(11;14).

CureusVol. 17(5)
Mohammed V University (MA), Military Hospital (PK), Centre hospitalier universitaire d'Orléans (FR)
Good health and well-being
Openalex Percentile: Top 86%
Multiple Myeloma Research and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Refractory Primary Duodenal Plasmacytoma Displaying t(11;14): A Report of a Rare Case — Marlène Ochmann, Nora El Maachi, et al. · Cureus (2025) | TGRS Research Map | TGRS